FDA Approvals Roundup: Qelbree, Sarclisa, Tyvaso Posted 07 April 2021 | By Renee Matthews  A weekly update on new drug approvals and indications from the US Food and Drug Administration (FDA). New approvalsQelbree okayed as nonstimulant therapy option for children with ADHDSupernus’s Qelbree (viloxazine extended-release capsules) has been approved for the treatment of  attention deficit hyperactivity […]

Dr. Wong Discusses Monoclonal Antibodies in Plasma Cell Neoplasms

LAUGH FOR A GOOD CAUSE: Bargatze to headline charity comedy event Laughs 4 Life returns for yet another night of comedic relief and fundraising Friday, July 30 at Hattiesburg’s historic Saenger Theater. Headlining this year’s event will be Nate Bargatze, one of comedy’s fasting-rising stars. Joining Bargatze will be special guest opener and fellow Tennessean […]

The Multiple Myeloma Research Foundation The Multiple Myeloma Research Foundation (MMRF) helps accelerate the development of next generation multiple myeloma treatments to extend patient’s lives, and lead to a cure. MMRF brings treatment to multiple myeloma patients 60% faster than the average through collaboration with best in class partners in the US and Internationally. In […]

MitoImmune Received FDA Clearance of IND Application for MIT-001, a Novel Anti-Inflammatory … – MitoImmune initiates a Phase 2 trial of oral mucositis (OM) prevention in the first half of 2021 in the US and Korea, and is expanding OM treatment into hematopoietic stem cell transplantation clinical trials SEOUL, South Korea, April 6, 2021 /PRNewswire/ […]

Whole-Genome Sequencing Shows Ability to Identify Progressive Myeloma Precursor In a cohort of patients with monoclonal gammopathy of undetermined significance (MGUS) or smoldering myeloma, whole-genome sequencing (WGS) identified disease-defining genomic events that successfully identified 2 distinct precursors of multiple myeloma that may be able to stratify individuals as having either progressive or stable disease entities.1 […]

Bispecific Antibodies for Multiple Myeloma Review of the development and mechanism of bispecific antibodies in multiple myeloma, and the panel reviews the supporting data. Website: https://www.onclive.com Twitter: https://twitter.com/OncLive Facebook: https://www.facebook.com/OncLive/ LinkedIn: https://www.linkedin.com/company/onclive

GenomeFrontier, Ziopharm Non-Viral Vectors Could Transform CAR-T Cell Therapy Ziopharm Chief Medical Officer Dr. Raffaele Baffa/Photo courtesy of Ziopharm Chimeric antigen receptor (CAR-T) therapy is one of the biggest cancer therapy breakthroughs of our time, but as with any precise science, there is still some fine-tuning to be done to overcome safety risks, limited payload […]

HEMA-4 Screening Tool Predicts Survival in Older Patients With Malignant Hemopathies A newly developed screening tool, HEMA-4, effectively predicted survival among older patients with malignant hemopathies. These findings, from a prospective study, were published in the Journal of Geriatric Oncology. This study was conducted to develop and validate a simple score to estimate survival in […]

Woman with multiple myeloma successfully treated Gurugram, Apr 4 (IANS): An elderly woman from Jammu, suffering from multiple myeloma for the past 10 years, was successfully treated at a private hospital here. Following the transplant, 62-year-old Raj Kapahi is now back to her normal life and is living a healthy life. As per the doctors, […]